Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
Health Canada Health Products & Food Regulatory Modernization
Health care system policies or programs with respect to pharmaceuticals
Patent Act as it relates to the regulation of intellectual property for therapeutic products
Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)
Patented Medicine Prices Review Board with respect to regulations of reporting obligations of patentees
Patented Medicine Prices Review Board with respect to the regulation of pricing of patented drug products
Policies or programs with respect to Federal Public Drug Benefit Programs
Proposed and potential policies with respect to current or potential regulation of cross-border trade in pharmaceuticals, including the Export Control List
Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy
Regulation
Food and Drug Regulations specifically with respect to approval, regulation and life-cycle management of therapeutic products
Food and Drug Regulations with respect to Data Protection under. C.08.004
Patent Act regulations as they relate to the regulation of intellectual property for therapeutic products and the Patented Medicines (Notice of Compliance) Regulations